Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Rocky
Does ACTC get the money when the warrants are exercised?
Let me know when they plan the r/s so I can get out.
4 UPON MOTION DULY MADE AND SECONDED,BY UNANIMOUS VOTE
the Board decided unanimously that a one-for-ten shares reverse stock split will be implemented and that the number of authorized shares will be reduced to 1.5 billion shares.The President and the Treasurer were directed to develop a plan for announcing such a split and for the implementation of this decision.The exact date of the split is yet to be set.
News
PANAMERSA CORPORATION (PNMS)
UPDATE
AUGUST 31, 2009
I want to wish you and your family a very happy Labor Day weekend.
Those that helped with the special offering deserve a special vote of thanks from all of us, as it is their efforts that have helped to keep PANAMERSA (PNMS) alive.
PANAMERSA has always been a long term investment that can yield great investment returns. The problem is no one knows when our assets will be released. I spoke with Pedro last week as he was flying home and he assured me that the PNMS assets were still in place waiting to be released at some future date. He agreed that we must bring our certified financials up to date, as real financials were last done almost three years ago.
The problem that I have is lack of sufficient funds to accomplish everything that needs to be done. The little amount of funds that I have to work with can not be used up in buying expensive opinion letters from attorneys while failing to pay needed bills and fees that keep PNMS in good standing. I will have a substantial amount of state and transfer agent fees due in October. Lack of sufficient funding slows things and stops things from happening.
THE CURRENT PLAN:
The plan in order of importance, which I hope I can accomplish, is as follows:
1--- I met with a CPA knowledgeable about PNMS and the problems that have occurred. He agreed to do the taxes for 2007 & 2008. He will also do the financial statements for these years. Pedro has said he will help with the financials as he is the protector of our assets. The quality and plausibility of these financials (determined by the audit and certification) will hopefully start our stock trading at higher prices
This is the missing link for PNMS as there has never been acceptable financials. When these financials are completed and released we will be able to be reclassified as a holding company with assets instead of a pink sheet shell company. We will have shares with little or no value until this occurs.
2--- I will again visit NATCO to set up a method of returning shares to the PNMS PDR owners and others caught in the PDR Exchange mess. The audit is not yet complete so please send in your audit information. I have secured legal advice as how to best handle the share return based on our PNMS financial position and SEC law. PNMS shares are currently worth little and hard to sell so their value will depend on our success with the financials and when our assets are released. I currently have only restricted shares in my possession and the transfer agency is not allowing transfers without legal opinions, which are expensive. The transfer agency is being extra cautious because of the way MST handled his security sales and transactions on the PDR Exchange. PNMS does not benefit its shareholders by doing partial or selective share returns under the circumstances.
3--- The reverse split that has often been discussed will likely be needed, but will be one that will be used to add value to the shares of our current shareholders and reduce our overhead in the form of regulatory fees. We want to be a reporting company headed for NASDAQ and to do so need a much higher share price and less authorized shares. This
reverse split will allow us to acquire or merge with companies that are in business and earning money. We must prepare to grow PNMS as we wait for the promised assets to arrive and without a reverse split we have no means to grow.
SUMMARY:
PANAMERSA has come a long way toward getting its act back in order, but unless we are able to accomplish the above steps we will remain a pink sheet shell.
We now have a highly respected attorney who specializes in securities law working with us. We have a transfer agency (NATCO) working with us. We have a CPA who knows about PNMS working with us. We have Pedro, a very influential man of great integrity and purpose, working hard to insure that the assets belonging to PNMS, will become identifiable as part of the corporation. Pedro will also be referring other companies to PNMS to help it grow.
I have until the end of October to have the above steps in motion as I just don’t have the funding to continue spending this much time wrestling with stock audits and restricted stock transfers. If all goes well we will be reorganized and ready to grow before the year is ended.
There are no guarantees we will succeed at everything we try to accomplish, but we will do out best to succeed in a lawful manner.
Again PANAMERSA thanks everyone for their support and patience during these difficult times. Some day soon even the greatest doubters will thank Pedro for his efforts on behalf of all the PNMS shareholders.
Please email me or call me at 702-405-7830 if you have any questions.
Regards and best wishes,
James Finegan ---- Vice President & Director
PANAMERSA Corporation
I cannot believe that somehow the thief Terrell and his douche bag Theresa is going to get a pass
hototc.com, which sends out free emails of daily stock alerts for penny stocks, has included GOVX in their alert for Monday with the following text:
GOVX - Momentum
http://www.chartmoney.com/stockquotes.php/?ticker=govx
GeoVax Labs, Inc., a clinical stage biotechnology company, engages in the research and development of human vaccines for diseases caused by human immunodeficiency virus (HIV) and other infectious agents.
Old but interesting
Don Hildebrand was just a few months into his retirement when he got the call from Rafi Ahmed, director of the Emory Vaccine Center.
Although Hildebrand, a 30-year veteran of the biopharmaceutical industry, was looking forward to reuniting with his hobbies and playing the stock market from his home in Athens, he was about to get pulled back into the business.
New technology developed by Emory scientist Harriet Robinson had protected 22 out of 23 monkeys from developing AIDS, and Ahmed wanted Hildebrand to help create GeoVax, a company to develop, manufacture and commercialize the potential vaccine.
Hildebrand agreed, and six years later he’s working out of a series of modular labs sequestered on Emory’s Briarcliff Campus. The yellow paneled buildings — filled with laboratory equipment, machinery, pipette tips and latex gloves — are a far cry from the high-powered corporate environment he used to inhabit. But some Emory officials and scientists say GeoVax is the world’s best hope for defeating the deadly AIDS virus.
The tiny company has yet to make any money — as of Sept. 30 it had lost more than $3 million this year due to increasing costs and zero cash flow — and it faces stiff competition from global pharmaceutical organizations like Eurovac and Merck. But Emory, which put up $750,000 to help create the company and owns $39.78 million in GeoVax stock, has pinned its hopes on Robinson’s unique approach to developing an AIDS vaccine.
The technology utilizes a dual-pronged approach to identify and then defend against AIDS, which is notoriously difficult to stop because the virus constantly mutates. GeoVax’s efforts were rewarded with a $15 million grant from the National Institutes of Health in September.
The first phase of human testing, started in 2004, proved the potential vaccine was safe for use, and the company hopes to begin the second phase in clinical trials with widespread tests during the middle of next year.
The Dynamic Duo
GeoVax’s scientific successes are a result of a close collaboration between Hildebrand and Robinson.
Robinson praises Hildebrand’s business savvy, crediting him with making the most of GeoVax’s relatively small budget.
“I have never seen someone squeeze as much value out of a nickel as he is able to do,” Robinson said. “If the vaccine becomes a reality, which we intend it to become, it will be due as much to his business skills as our having started a good product through the pipeline.”
Hildebrand, a gregarious, heavyset man, has always had an eye for turning a profit. As an undergraduate at the University of Wisconsin-Madison, he and a classmate imported and sold Sri Lankan batik paintings to make a few bucks on the side.
About 12 people, mostly scientists, work at GeoVax directly, with several individuals working at other locations. Contractors around the world are hired to manufacture the vaccine.
After four years, GeoVax entered a reverse merger with Dauphin Technology Inc., making it a public company and opening it up to receive further investment. In the last six years, Hildebrand said, the company has received at least $50 million in private investments and grant money. Emory remains the largest shareholder, owning slightly more than 30 percent of GeoVax.
Hildebrand admits a larger budget would help push development and testing at a faster pace. But like others at Emory, he has placed his faith in Robinson’s technology, which lies at the heart of GeoVax’s mission.
“Working with Dr. Robinson is absolutely fabulous as she is an extremely wonderful person, exceptionally talented and a true pleasure to work with,” Hildebrand said.
Most HIV vaccines involve vaccine vectors. A vaccine vector is a weakened version of a virus that carries a protein recognized by the body as foreign, from a disease-causing agent.
The vector delivers the protein to the body and stimulates the immune system to act, “fooling” it into generating an immune response against the foreign protein.
But GeoVax takes another approach. The base technology for the vaccine, a DNA/MVA combination currently under patent review, was developed by Robinson and is different from competitors because it utilizes broad immune responses to combat multiple HIV proteins — the same concept that is behind multidrug therapy.
“It is much harder to escape three drugs than one — similarly, it is much harder to escape a multi-target immune response,” Robinson said.
Two virus types compose the vaccination. The DNA part works by injecting viral genes into healthy cells. This boosts the immune response against individual parts of the virus. Then, upon infection, these antibodies are more likely to recognize and destroy the virus, even if some viral genes have gained mutations.
Then the MVA component, which is a modified smallpox virus, creates a focused immune response to HIV. Although the vaccine would not prevent a HIV infection, it would prevent the development of AIDS and the destruction of the immune system.
Robinson was recruited by Emory from the University of Massachusetts School of Medicine and took up a position as the chief of the Division of Microbiology and Immunology at Yerkes National Primate Research Center in 1998.
By the time she arrived at Emory, the vaccine had been subjected to more than 15 years of trials in non-human primates. These trials revealed that the vaccine stimulated the right kind of immune responses that would protect against the development of AIDS when a person is infected with the HIV virus, Hildebrand said.
Staying One Step Ahead
At the HIV Vaccine Trials Network (HVTN) meetings in Seattle in early November, it was announced that a potential vaccine produced by Merck had failed in ongoing trials in the United States and Africa. More people developed HIV in the vaccine group compared to the placebo group.
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said in a statement on the NIAID website that the new analyses were “disappointing and puzzling” and that “failure of this HIV vaccine product was unexpected.”
Merck Public Affairs Director Nalini Saligram said the vaccine was clearly not working, a “disappointing finding.” Because no live HIV virus was used in making the vaccine, she said the vaccine itself could not have caused HIV.
“We are wondering whether [the results were] due to chance, due to the vaccine itself, or due to some biological phenomenon we do not quite understand yet,” Saligram said.
The recent vaccine setback did not affect the GeoVax vaccine, based on a different technology.
“GeoVax AIDS vaccines showed better protection in the non-human primate models than anybody else. That protection is likely to carry over to humans,” Hildebrand said. “That is something the other vaccine companies have not been able to develop or prove.”
GeoVax also believes it may be able to help treat as well as prevent AIDS. Preliminary work is being performed by Emory scientist Rama Amara on monkeys already infected with the AIDS virus but still have intact immune systems.
The monkeys are put on drug treatment programs using the GeoVax vaccine to reduce the virus level in the body of individuals, then vaccinated with the GeoVax DNA and MVA vaccines and taken off the drug program.
Drug treatment programs have severe negative side effects and can cost from $15,000 to $75,000 per year, a significant hurdle for developing countries and many patients in the U.S.
“If we can develop a program where we can vaccinate people already infected with the virus but still have an intact immune system, we may have a way to economically protect these people
Acap pulled out thanks
Come on Acap get out of the way
Something very positive is up besides just tha Bio Ceo conference
did anything come out of the FBI meeting
Let us not get carried away with diversionery tactics.It is imperative for us to make sure that Mike Terrell and Theresa Rogers go to jail.I will do my part to help.
Its time to put these guys away in a slammer.Greed such as Rod Blogojevich and these guys Mike and Theresa belong in jail.
What I want to know is how does one raise their kids,deal with their neighbors and consistently lie and deceive people? No conscience no feelings just greed and disception.
Re:Panamersa
From:rogers32349@aol.com
Sent: Sat 2/02/08 2:30 am
Ed.you know I adore you but I have my instructions as well-I hope Micheal has honored his commitment to you-I have no control over monies only over being the one who takes the garbage all the time and I am really tired of it--I don't know what my position is at all right now--He is the man-but I consistently pressure him to do what is right-Physically,I am struggling but I will make this right for you if I have ultimately to take it out of my own pocket--
It may take a while-but I gave my word based on others so therefore it leaves me to my word only-when I can you will get what you were promised--I adore you-I am too embarrassed to talk to anyone right now-so many changes and so little communication even for myself--stay with me-I will not I repeat I will not let you down.Print this off and save it--I want you to know that I meet my personal obligations--
I'll call you when I have this sorted out-you are my favorite and you know that--keep this between you and me--I wont let you down.
Ellen ,put me down for the lawsuit.
Maybe we should chip in and send some boys from Chicago to get their attention first.This ending is not acceptable.They should realize that cheats get hurt for a lot less than that.Lets go from all fronts.
Re: Panamersa
From: rogers32349@aol.com
Sent: Sat 11/08/08 3:43 PM
Theresa, for the world of me I cannot believe that you were a part of the scheme to defraud good honest people.How sad.
I was not, Ed - on my daddy's grave-- I swear it
Heres the crook
RE: Money
From: Mike Terrell (mike@pdrex.com)
Sent: Mon 11/24/08 3:28 PM
To: rogers32349@aol.com; airhawk8@hotmail.com; advocates4women@yahoo.com; brenda@bluehavenhomes.com; ddunn004@tx.rr.com; EdRimkus@hotmail.com; Gum610@aol.com; Haironfiremach3@aol.com; istsbosmass@yahoo.com; joe@e-a.net; latintx48@yahoo.com; RoyHOA@aol.com; Rinderles@yahoo.com; tdaycompany@yahoo.com; nigel.menezes@gmail.com; peeop@suddenlink.net
2 attachment(s)
image001.jpg (12.6 KB), image002.gif (42.8 KB)
But PDR exchange is not FUNDAPAN
Does it make any sense that an indicted person would give a damn about our presidentil election?
How are you going to prove #6 proof of conveyance into FUNDAPAN?
http://www.ceocfointerviews.com/index.html
very interesting interview
I sure would like for some of the former moderators like 4GOD to weigh in.You used to claim MT is your friend. You were also claiming to be a religious person.Forgive me but my religion teaches honesty in our daily endevors.A response from you would be welcome.
OA, how do you think Pedro will end this investigation?
Maybe they can buy back the shares that are missing? I can not believe that they are all missing.Lets buy them back,they are selling cheap at 0001 to shore up the books and pay off the people that have monies coming.
Anybody care to weigh in on this blog?
Check out the PDR exchang new front
For some reason they wont give me any 0004s
I wonder why they wont sell me any at 0004. The order has been in for quite a while
OA,this is not a Ponzi scheme.In a Ponzi scheme some of the first people get paid.This has not been the case.
Can somebody post Pedros telephone number.
This company is like a mutual fund.Where does a mutual fund gets its money? Someday it will all shake out.
Who makes a trade for a total of 3cents?
Did anybody posting here get any of the 2s that are going off?
Have you heard anything in Spain about the ongoing meetings with Pedro and Mike?
Sorry I missread your post yesterday.On another note since you are from Spain and you seemed to know a lot about Desimplex, what is your opinion about the PDR exchange upcoming in Spain? Will it be a great plus for us? I understand that people in Spain have a lot of money to invest.
Yesterday you said you had 83M. Did you sell 75M yesterday?
Your 83000 shares is not going to help you much.
For those of you who are in this US market,I see only one way to make some money.Here is how.You buy a lot of PNMS at these prices.Then a few chip in to come up with about 20000 dollars.You hire Jonathan Lebed to promote and pump this stock.He does this and he might even get some help when the quaterly earnings are announced.Price goes up considerably since he has a huge following now and has been hot lately.You bail out much higher.There is no chance just waiting for something to happen.IMO
How are you going to pay for the certs that you are guaranteeing? If you dont have any money dont make phoney promises or deals.